Invivoscribe Revenue and Competitors
Estimated Revenue & Valuation
- Invivoscribe's estimated annual revenue is currently $37.8M per year.
- Invivoscribe's estimated revenue per employee is $155,000
Employee Data
- Invivoscribe has 244 Employees.
- Invivoscribe grew their employee count by 7% last year.
Invivoscribe's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder, CEO, CSO & Chairman | Reveal Email/Phone |
2 | CFO | Reveal Email/Phone |
3 | CIO | Reveal Email/Phone |
4 | Head Global Sales and Marketing | Reveal Email/Phone |
5 | Sr. Director Product Development | Reveal Email/Phone |
6 | Global Operations Director | Reveal Email/Phone |
7 | Global Director Regulatory, Quality, and Clinical Affairs | Reveal Email/Phone |
8 | Global Director Facility Management | Reveal Email/Phone |
9 | Chief Medical Officer | Reveal Email/Phone |
10 | Director, Manufacturing and Supply Chain | Reveal Email/Phone |
Invivoscribe Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Invivoscribe?
Invivoscribe is dedicated to improving the quality of healthcare worldwide by providing high quality, reliable, cutting-edge tools for molecular biology, molecular diagnostics, and Personalized Molecular Medicine. Products manufactured in our GMP facility include a comprehensive selection of PCR-based reagents and controls for gene rearrangement, chromosome translocation, and gene mutation testing. Customers include pharmaceutical and biotechnology companies; cancer research, academic and hospital testing centers, and reference laboratories. Our CE-marked IVD products, which are available for sale and use outside North America, target biomarkers that have demonstrated clinical utility. Our tests are used to identify, stratify and monitor hematologic cancers. Our companion diagnostic products assist in the development of pharmaceutical agents and devices. Many of our gene rearrangement and gene mutation testing products are covered by exclusive-licensed patents.
keywords:Biotechnology,Healthcare
N/A
Total Funding
244
Number of Employees
$37.8M
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $40.3M | 244 | N/A | N/A |
#2 | $72.5M | 244 | -4% | N/A |
#3 | $77M | 244 | 9% | N/A |
#4 | $37.9M | 246 | 5% | N/A |
#5 | $40.6M | 246 | -7% | N/A |